Recent Quotes (30 days)

You have no recent quotes
chg | %

Premier Diagnostic Health Services Inc  

(Public, CNSX:PDH)   Watch this stock  
Find more results for PDH
0.0000 (0.00%)
Jan 17 - Close
CNSX real-time data - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.10
Open     -
Vol. 0.00
Mkt cap 760,861.00
P/E     -
Div/yield     -
EPS -0.02
Shares 50.72M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin -441.64% -483.17%
Operating margin -441.64% -483.17%
EBITD margin - -293.76%
Return on average assets -55.06% -54.29%
Return on average equity - -568.56%
CDP Score - -


Suite 301, 3185 Willingdon Green
+1-604-6789115 (Phone)
+1-604-6789278 (Fax)

Website links


Premier Diagnostic Health Services Inc. is a Canada-based company, engaged in the business of establishment of Diagnostic Imaging Centers in Canada and China, together with an integrated support services infrastructure, utilizing of Positron Emission Technology (PET) and/or Magnetic Resonance Imagining (MRI) technologies, and the establishment of facilities for the commercial production of Health Canada-approved CanTrace fluorodeoxyglucose (FDG), the radiopharmaceutical used in PET scanning, for use and sale. As of September 30, 2012, the Company had 100% interest in Premier Diagnostic Health Services (Vancouver) Inc.; Petscan International (Hong Kong) Limited, and Beijing Premier International Medical Equipment Technology Services Corporation Limited (Premier Beijing).